The Coming Crash in Biotech Stocks
With Profits Down By 52 Percent, Pfizer (PFE) Investors May Pressure for an M&A, a Breakup, or Both
Google Inc. (GOOG) Forays Deeper Into Healthcare By Partnering Up With Biogen Idec (BIIB)
Spurred by Biotech's Rapid Growth, Banking Giant Taps First-Ever Boston Staffer to Focus on Supercluster
AstraZeneca PLC (AZN) Rumored to be Stalking Massachusetts's Ariad Pharmaceuticals, Inc. (ARIA)
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK)
Merck & Co. (MRK)'s Fake MMR Trial Data Buried Even as Measles Outbreak Shows Vaccine Surge
Pfizer (PFE) Strikes $400 Million Deal to Avert Investor Class Action Trial
Hidden Spy Camera Discovered in Johnson & Johnson (JNJ) Bathroom, Say Police
Amgen (AMGN) Submits Applications for Cancer Drug Kyprolis in U.S. and Europe
Novartis AG (NVS) Sees Price War With Amgen (AMGN), Eli Lilly (LLY) for Blockbuster Psoriasis Market
BioMarin (BMRN) Rewrites Playbook for How Rare Disease Drugs Are Approved
Duke University Expands; Partners Up With Google Inc. (GOOG) to Study What Makes a Healthy Human
EXCLUSIVE: Novartis AG (NVS), Amgen (AMGN) and Pfizer (PFE)’s Push Into Early Stages Exciting, But “Secret Sauce” Is Crucial, Says VC
Schoolgirl Comment Points To Antibiotics As New Cancer Treatments, University of Manchester Study
Amgen (AMGN) Submits Applications In The U.S. And Europe For Kyprolis (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma
Gene That Makes You Live Longer Might Make You Smarter Too, University of California, San Francisco (UCSF) Study
Revealed: The Sex Lives Of The Over-70s, University of Manchester Study
See All News >